CBDNewsBreaks – Vantage Hemp Co. is in the Final Stages of its DMF Submissions

January 25, 2022 14:29:39

The usage of CBD as an active pharmaceutical ingredient is creating an overwhelming need for CBD manufacturers to identify their processes used in the manufacturing, packaging, and storing of pharmaceutical drug ingredients. On their way to set the industry bar, Colorado-based CBD manufacturer, Vantage Hemp Co., announces the company is in its final stages of its Drug Master File submissions to the US Food & Drug Administration. As one of the first CBD companies to file DMFs for all of its ingredients, Vantage is providing the FDA with confidential and detailed information about the quality and safety of its products. These submissions can be referenced by Vantage’s pharmaceutical partners when applying for FDA approval of their drug product.

To view the full press release, visit https://cnw.fm/fS9Hq

About Vantage Hemp Co.

With large-scale extraction facilities, Colorado-based Vantage Hemp Co. delivers pharmaceutical-grade GMP compliant CBD extracts (including full-spectrum oil, distillate and isolate) that companies can trust. Vantage’s contract manufacturing services offer a broad range of benefits as they operate with integrity and abide by stringent pharmaceutical-production standards to provide quality products to their partners.

Brooke Russell

Marigold Marketing & PR



About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.